Navigation Links
Acrylamide Raises Kidney Cancer Risk
Date:5/9/2008

Study found high intake of compound in fried foods, snacks, coffee upped chances of disease

FRIDAY, May 9 (HealthDay News) -- Consuming large amounts of acrylamide, a chemical commonly found in French fries, cakes, snacks and even coffee, appears to raise the risk of kidney cancer, especially in smokers, Dutch researchers report.

"Ours is the first report of a positive association between dietary acrylamide intake and renal cell [kidney] cancer," said study author Janneke Hogervorst, a researcher at Maastricht University in the Netherlands.

The report is published in the May issue of the American Journal of Clinical Nutrition.

Studies of the chemical have been ongoing since 1994, when the International Agency for Research on Cancer classified the chemical as a probable human carcinogen. Experts thought the main exposure was environmental, through cigarette smoke and, to a lesser extent, cosmetics.

But in 2002, Swedish scientists reported the presence of the chemical in carbohydrate-rich foods produced at high temperatures, including French fries and potato chips.

Studies of the chemical's link to various cancers have yielded mixed results.

The Dutch research team took data from the Netherlands Cohort Study on diet and cancer, which includes more than 120,000 men and women, aged 55 to 69. They followed them for more than 13 years, looking at all the cases of kidney, bladder and prostate cancers. They took a random sample of 5,000 people to look at their dietary habits.

The average intake of acrylamide from the diet was 21.8 micrograms -- a little less than what is included in a 2.5-ounce serving of French fries. Those who took in the most -- averaging 40.8 micrograms a day -- had a 59 percent higher risk of kidney cancer (but not the other cancers) than those consuming the least.

For most people, coffee was the major source of the chemical. However, a popular
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Acrylamide Wont Raise Breast Cancer Risk
2. Reese Witherspoon Helps Celebrate Avon Walk for Breast Cancer Washington, D.C. - Weekend-Long Event Raises $8.1 Million
3. Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
4. Study raises questions about prostate cancer therapies targeting IGF-1
5. Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence
6. USCCB Official Praises Senate Passage of Genetic Information Nondiscrimination Act
7. The Womens Health II Medical Education Network Raises Awareness About the Diagnosis and Management of Womens Health Issues
8. VisEn Medical Raises $5.0 Million in Expanded Series B Financing
9. Consumer Watchdog Praises CA HMO Regulators Promise to Reinstate Health Coverage for Wrongfully Cancelled Patients; Cautions That All Health Costs During Gap Must be Covered
10. FRC Action Praises John McCains Pro-Life Comments
11. Standard & Poors Raises Gerresheimer Rating to BB+
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Acrylamide Raises Kidney Cancer Risk
Acrylamide Raises Kidney Cancer Risk
(Date:5/20/2008)...alth care problem all over the world, with 130 mil...nt is expensive and has variable results according... land mark in treatment is the virus clearance at ...onse (ETR), but many of the patients achieving the...us, the goal of treatment is to have persistent vi...
(Date:5/20/2008)...erless prescription use yields practical guides fo...nd policy makers, WASHINGTON, MAY 20 /PRNewswire-...eHI) and the Center for Improving Medication Manag... anticipated report detailing the,impact of electr...,consumers, employers, health plans and policy mak...
(Date:5/20/2008)...APOLIS, May 20 /PRNewswire/ -- On May 25, one brig...Honda, will be racing to win,the Indianapolis 500 ...s --,Eyes on the Road. By emblazoning their car on...tp://www.eyesontheroad.org, IndyCar owners Jay Pe...s driver, IndyCar Series,veteran Tomas Scheckter o...
(Date:5/20/2008)...nhaling long, thin carbon nanotubes may result in,...ewswire-USNewswire/ -- A major study published,tod... carbon nanotubes -- a,poster child for the "nanot...bestos if inhaled in sufficient quantities., The ...types of,nanotubes have the potential to cause mes...
Breaking Medicine News(10 mins):Health News:eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results 2Health News:eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results 3Health News:Luczo Dragon IndyCar Carries 'Eyes on the Road' Logo to Prevent Blindness to Indy 500 2Health News:Carbon Nanotubes That Look Like Asbestos, Behave Like Asbestos 2Health News:Carbon Nanotubes That Look Like Asbestos, Behave Like Asbestos 3Health News:Carbon Nanotubes That Look Like Asbestos, Behave Like Asbestos 4
...ly of enzymes called sirtuins, which can dramatica..., worms, and flies. Now, a new study from scienti...tegy for activating sirtuins to unleash their anti...o control age-associated metabolic disorders, incl...
... professor in Indiana University Bloomington's Dep...ome tips to help parents of teenagers have a conve...ge is the most difficult phase in the process of g...tegral part of this mind-boggling time. The resear...
... Biotech have been developing a harmless virus as ...accumulating data that suggests in addition to dir...the immune system to mount a separate, powerful an... Evidence for this theory has been mounting for ...
...cal journal The Lancet claims that a newer class o...his research carried out by Merck employees was co...dently. Patients suffering from arthritis general...s (NSAIDS) like Aspirin and ibuprofen. Ulcers and ...
Other Medicine News:Health News:Anti-Aging Powers of Enzyme Sirtuins 2Health News:Scientists Develop a Harmless Multi-Tasking Reovirus 2
(Date:5/19/2008)... Nektar Therapeutics present preliminary Phase II ...ia in intubated and mechanicall... /- Bayer HealthCare,togeth...y presented positive,preliminary Phase II data on ...le at the American Thoracic Society (ATS) annual m...
(Date:5/19/2008)...Be Presented at the 2008 Annual European Congress ...Against Rheumatism (EULAR) -, - Initiation of Pha... of 2008 -, SAN D...iences, Inc.,(Nasdaq: RDEA ) today announced the ...or the treatment of patients with gout, RDEA594. G...
(Date:5/19/2008)..., May 19 /- IPSOGEN SA (Marseille and...arkets molecular diagnostic,assays for blood & bre...,the University of Texas MD Anderson Cancer Center...two studies on the Genomic Grade index (GGi) at th... to June 3, 2008. The data,indicate that the Genom...
(Date:5/18/2008)...a Demonstrated Higher Overall Maintenance of Heale...rsus Placebo --, SAN DIEGO, May 18 /...results from three pivotal Phase 3 studies evaluat...proton pump inhibitor (PPI),with an innovative dua...with erosive esophagitis (EE) and in maintenance o...
Breaking Medicine Technology:Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 2Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 4TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 2TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 3TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 4Breakthrough in Pulmonary Drug Delivery will Bring Numerous In Hospital Treatments to the Home 8547 1Breakthrough in Pulmonary Drug Delivery will Bring Numerous In Hospital Treatments to the Home 8547 2LineaGen Inc Launches With Close of 245 8 Million Series A Funding Round 2302 1LineaGen Inc Launches With Close of 245 8 Million Series A Funding Round 2302 2LineaGen Inc Launches With Close of 245 8 Million Series A Funding Round 2302 3LineaGen Inc Launches With Close of 245 8 Million Series A Funding Round 2302 4Possible New Way to Detect Monitor Liver Disease Without Painful Liver Biopsy 2297 1Possible New Way to Detect Monitor Liver Disease Without Painful Liver Biopsy 2297 2Skatepark injuries can incur economic pain 8540 1Skatepark injuries can incur economic pain 8540 2
...-(BUSINESS WIRE)--Apr 13, 2007 - Point Therapeutic... presentation of,preclinical data at the 2007 Annu...Research (AACR) taking place in Los Angeles,Calif...tions report,on preclinical studies on talabostat,...or the AACR presentations are as,follows: , Presen...
...GO--(BUSINESS WIRE)--Apr 13, 2007 - Ascenta Therap...le portfolio of,apoptosis-triggering compounds wil...ral poster presentations at next week,s 2007,Annua...esearch,(AACR), to be held in Los Angeles, Califor... been selected for presentation at the,"High Impac...
Other Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6
Siemens Webcast: Expert Insight - Key Elements for a Successful Electrophysiology Program
...LEXILOG antimony pH catheters are designed for pat...ll catheters are number marked at 5cm intervals an...en individual models are available spanning most c...se or multi-use models with one or two sensors., ...
...limline multi-use catheters are designed using est...ution with the following benefits:, ,Working with...res where the multi-use catheter is used the Helli...n.,NOTE: ,Medtronic pH measurement systems have be...
FLEXILOG spare part.
Medicine Products: